International CML Foundation

International CML Foundation Improving outcomes for patients with CML globally. The International CML Foundation (iCMLf) is on a mission to improve outcomes for patients with CML, globally.

Founded by a dedicated group of hematologists, we are committed to ensuring every patient with CML, no matter where they are in the world, receives the best possible care. We foster international collaboration to elevate knowledge, enhance diagnostics, and drive ground-breaking research. As a charitable foundation with a global reach, we strive to empower physicians, researchers, patients and caregivers alike, in the collective pursuit of a cure. Join us and contribute to a world where a cure for CML is not just a hope, but a reality.

📬 The iCMLf newsletter is landing in inboxes today.It’s the easiest way to stay up to date with what’s happening across ...
22/01/2026

📬 The iCMLf newsletter is landing in inboxes today.

It’s the easiest way to stay up to date with what’s happening across the global CML community – from calls and opportunities, to programme updates, research highlights, and ways to get involved.

If you’re not subscribed yet, now’s the moment.
đź”— Sign up and stay connected: https://buff.ly/w0ZrUfi

Reminder: Call for iCMLf PrizesA quick reminder that nominations for the 2026 International CML Foundation Prizes are st...
21/01/2026

Reminder: Call for iCMLf Prizes

A quick reminder that nominations for the 2026 International CML Foundation Prizes are still open.

Do you know a clinician, researcher, or programme making an outstanding contribution to CML care, research, or education? Help us recognise excellence across the global CML community.

🗓️ Nominations close soon
đź”— Submit your nomination: https://buff.ly/f6B5lNb

Please share within your networks.

Meet Rihab Nasr, who is one of the incredible climbers who will be trekking the Avenue of Volcanoes in Ecuador this Febr...
20/01/2026

Meet Rihab Nasr, who is one of the incredible climbers who will be trekking the Avenue of Volcanoes in Ecuador this February!

Rihab is a cancer researcher focused on developing targeted therapies for leukemias and biomarkers for early cancer detection. She is also the founder of AMALOUNA, an American University of Beirut-affiliated organisation dedicated to fighting cancer through awareness, prevention, and research.

This February, Rihab and her daughter will join a team of scientists, oncologists, advocates, and CML patients climbing for a cure.

"I believe scientific research does not happen in a vacuum. Scientists belong to a community that extends beyond geographic borders with the unique goal of spreading knowledge and finding solutions to major health issues such as cancer," says Rihab.

Support her journey and help us advance CML research and care worldwide: climb-for-a-cure.raiselysite.com

⏳ Last call – happening tomorrowJoin us tomorrow, Tuesday 20 January, for the next iCMLf Conversation: Highlights of ASH...
19/01/2026

⏳ Last call – happening tomorrow

Join us tomorrow, Tuesday 20 January, for the next iCMLf Conversation: Highlights of ASH 2025.

🎙 Speakers
• Kateřina Machová Poláková – Biology of CML
• Ehab Atallah – Clinical updates from ASH 2025

đź“… Tuesday 20 January 2026
🕑 14:00–14:45 CET
🖥️ Live on Zoom

Whether you attended ASH or not, this is a concise, expert-led summary of the key takeaways for the CML community.

👉 Register now
https://buff.ly/yBbQ4jE

19/01/2026

đź”” BREAKING NEWS!
The on-demand content of is now FREELY available to all on the ESH eLearning Centre. To access pdf presentations, videos and discussions, click here ➡ bit.ly/3YwfO1h
ESH- 27th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy
This international conference took place in Estoril, Portugal, on October 10-12, 2025, under the scientific direction of Professors Jorge Cortes, Tim P. Hughes and Daniela S. Krause.

International CML Foundation British Society for Haematology Sociedade Portuguesa de Hematologia

We're excited to introduce Yasmina Al Ghadban, who is one of the inspiring climbers taking on the Avenue of Volcanoes in...
15/01/2026

We're excited to introduce Yasmina Al Ghadban, who is one of the inspiring climbers taking on the Avenue of Volcanoes in Ecuador this year!

Yasmina is a PhD student in Women's Health and an aspiring future physician. As the daughter of a cancer researcher, she was immersed in conversations about CML from an early age, learning about its treatment and witnessing the transformative impact of research on patient outcomes.

This February, Yasmina and her mother will embark on this challenging trek together, joining a team of individuals committed to advancing CML research.

Support her journey and help us advance CML research and care worldwide: climb-for-a-cure.raiselysite.com

⏰ Reminder: iCMLf Conversation – Highlights of ASH 2025Join us next Tuesday for our next iCMLf Conversation, where two i...
14/01/2026

⏰ Reminder: iCMLf Conversation – Highlights of ASH 2025

Join us next Tuesday for our next iCMLf Conversation, where two international experts will distil the most important biological and clinical updates in CML from the 67th Annual Meeting of the American Society of Hematology.

This 45-minute session is designed to cut through the volume of data and focus on what truly matters for research and clinical practice.

🎙 Speakers
• Kateřina Machová Poláková – Key biological insights from ASH 2025
• Ehab Atallah – Clinical impact and practice-relevant updates

đź“… Tuesday 20 January 2026
🕑 14:00–14:45 CET
🖥️ Live on Zoom

Whether you attended ASH or not, this is a concise, expert-led overview of the CML highlights you need to know.

👉 Register now
https://buff.ly/yBbQ4jE

CML doesn't discriminate, but access to treatment does.While patients in some countries have access to life-saving medic...
12/01/2026

CML doesn't discriminate, but access to treatment does.

While patients in some countries have access to life-saving medications and cutting-edge care, millions of others face barriers that put their lives at risk.

We climb to change that – to ensure everyone with CML, everywhere in the world, has access to the care they deserve.

Help us bridge the gap: climb-for-a-cure.raiselysite.com

Join the next iCMLf Conversation: Highlights of ASH 2025Didn’t make it to ASH? Or want a clear, expert-led distillation ...
10/01/2026

Join the next iCMLf Conversation: Highlights of ASH 2025

Didn’t make it to ASH? Or want a clear, expert-led distillation of what really matters for CML?

On Tuesday 20 January 2026, two international experts will unpack the key biological and clinical takeaways from the 67th Annual Meeting of the American Society of Hematology - cutting through the noise to focus on what’s most relevant for practice and research.

Speakers
• Kateřina Machová Poláková – Biology of CML and implications for future research
• Ehab Atallah – Clinical impact of key CML studies from ASH 2025

đź“… Tuesday 20 January 2026
🕑 14:00–14:45 CET
🖥️ Live Zoom webinar

Whether you attended ASH or not, this session is designed to give the CML community a clear, practical overview of the most important developments.

👉 Register now and reserve your place
https://buff.ly/yBbQ4jE

We're making progress! Check out where we stand on our Climb for a Cure fundraising journey:Over $85,000 so far!Every do...
09/01/2026

We're making progress!

Check out where we stand on our Climb for a Cure fundraising journey:
Over $85,000 so far!

Every donation brings us closer to improving CML research and patient care around the world.

With less than two months to go, help us reach our $150,000 goal!

Support our climbers here: climb-for-a-cure.raiselysite.com

🎙️ New interview: Prof. Susan Branford on genomics in CMLDuring the 2025 Annual Meeting of the American Society of Hemat...
09/01/2026

🎙️ New interview: Prof. Susan Branford on genomics in CML

During the 2025 Annual Meeting of the American Society of Hematology, Professor Susan Branford (SA Pathology, Adelaide) presented the first analysis from the International CML Foundation Genomics Alliance using data from the HARMONY Alliance Foundation Platform.

In an interview conducted by the HARMONY Alliance Foundation, Prof. Branford discusses how somatic mutations present at diagnosis in patients with chronic phase CML receiving frontline imatinib are associated with a higher rate of treatment failure, and what these findings mean for risk stratification and personalised care.

👉 Watch the full interview: https://buff.ly/pqOvGwu

Every year, the iCMLf recognises exceptional contributions to CML research, clinical care, and global access through the...
08/01/2026

Every year, the iCMLf recognises exceptional contributions to CML research, clinical care, and global access through the iCMLf Prizes. These awards celebrate the scientists, clinicians, and advocates whose work has shaped progress in CML worldwide.

Nominations for the 2026 iCMLf Prizes are now open.
If you know a colleague, mentor, or collaborator whose work has made a lasting impact, we invite you to put their name forward.

đź”— Submit a nomination here: https://buff.ly/f6B5lNb

Address

Bexhill

Website

Alerts

Be the first to know and let us send you an email when International CML Foundation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category